Verbatim response from ChatGPT
Short answer
- Compounded semaglutide can work, but it’s riskier than using FDA‑approved products (Wegovy, Ozempic, Rybelsus) because potency, sterility, and labeling aren’t guaranteed. Use compounded only when there’s a clear medical reason and a trustworthy prescriber + accredited compounding pharmacy.
Why compounded versions are riskier
- Not FDA‑approved: no standardized manufacturing/inspection for that specific preparation.
- Potency and dosing may vary (too weak → ineffective; too strong → hypoglycemia, nausea, other harms).
- Sterility concerns for injected products → risk of local infection or serious bloodstream infection.
- Storage, handling, and labeling may be inconsistent.
- Supply chain/ingredient quality may be uncertain.
When a compounded product might be appropriate
- Allergies to an excipient in the commercial product, or a dose/formulation not commercially available and prescribed for an individual patient — and only when an experienced clinician and an accredited compounding pharmacy are involved.
How to avoid sketchy providers — practical checklist
-
Prefer FDA‑approved products first
- Wegovy (Novo Nordisk) — approved for chronic weight management.
- Ozempic (Novo Nordisk) — approved for type 2 diabetes (also used off‑label for weight loss).
- Rybelsus — oral semaglutide. If one of these is appropriate for you, it’s the safer route.
-
Use a legitimate prescriber
- See your primary care doctor, an endocrinologist, or an obesity medicine specialist (academic centers like Mayo Clinic, Cleveland Clinic are reputable options).
- If using telehealth, use established services that require a real medical evaluation and follow‑up rather than instant prescriptions with no history/exam.
-
Use an accredited compounding pharmacy when necessary
- Verify the pharmacy is licensed by your state Board of Pharmacy.
- Look for PCAB accreditation (Pharmacy Compounding Accreditation Board) and USP <797> sterile compounding compliance.
- Ask the pharmacy for sterility testing/certificates of analysis and the source of the active pharmaceutical ingredient (API).
-
Ask these questions of any provider or pharmacy (and insist on clear answers)
- Why is compounded semaglutide needed instead of an FDA product?
- Is the prescriber board‑certified (name and specialty)?
- Is the compounding pharmacy PCAB‑accredited and USP‑797 compliant?
- Can you provide lot testing/sterility certificate or certificate of analysis?
- How is the product shipped and stored (cold chain requirements)?
- What follow‑up, monitoring, and reporting of side effects will occur?
-
Red flags — walk away if you see any of these
- Prescriptions issued without a proper medical evaluation, lab work, or follow‑up.
- Extremely low prices or bulk offers for injectable vials delivered without counseling.
- No pharmacy license number, no pharmacist name, or refusal to share sterility/quality documentation.
- Shipping from overseas pharmacies with no U.S. license/inspection.
- Pressure to pay up front by nonstandard methods, or no written instructions for storage/use.
Resources and standards to check
- Your state Board of Pharmacy website (verify license).
- Pharmacy Compounding Accreditation Board (PCAB) status.
- Ask about USP <797> for sterile compounding.
If you want help
- Tell me the provider or pharmacy name/website and I can help you evaluate red flags and what to ask them.
- If you’re looking for a safe route to start semaglutide for weight loss or diabetes, I can help you draft questions for your clinician or suggest how to find a local endocrinologist/obesity specialist.